Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined traditional Chinese and Western medicine therapy study in chronic hepatitis B with mildly elevated ALT
ChiCTR-TRC-09000594Phase 4Completed
- Sponsor
- Shuguang Hospital
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of entecavir and Lingmao Granules in Chronic Hepatitis B (CHB) (4 arms), sponsored by Shuguang Hospital. Primary endpoints: HBV DNA, Liver biopsy and 4 more. Started Dec 2008; status: completed.
02
Drugs
entecavirLingmao Granules
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-09000594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000594.